PSC
GH icon

Portman Square Capital’s Guardant Health GH Stock Holding History

Portman Square Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,474
Closed -$256K – 370
2023
Q4 		$256K Sell
9,474
-31,747
-77% -$833K 0.01% 418
2023
Q3 		$1.22M Hold
41,221
– – 0.03% 351
2023
Q2 		$1.48M Buy
+41,221
New +$1.18M 0.04% 273

Other funds holding GH

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
TI
TrueMark Investments Chicago, Illinois $798M AUM 25.52% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $276M AUM 31.26% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
ITFISA
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Warsaw $300M AUM 61.93% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Portman Square Capital's GH Position: Q1 2024 in Review

Portman Square Capital sold out of Guardant Health (GH) in Q1 2024, closing a stake of 9,474 shares — an estimated $256K sold.

Portman Square Capital first reported a position in GH in Q2 2023 and held it in 3 quarters. The position peaked at $1.48M in Q2 2023. 257 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Portman Square Capital reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Portman Square Capital sold 9,474 Guardant Health shares in Q1 2024, an estimated $256K.
  • Portman Square Capital first reported a position in Guardant Health in Q2 2023 and held it in 3 quarters.
  • Portman Square Capital's Guardant Health position peaked at $1.48M in Q2 2023.
  • 257 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Portman Square Capital's 13F filing for Q1 2024, filed 15 Apr 2024.